You are here

obesity

Novo Nordisk Inks Potential $255M Deal with EraCal, Targets Another Obesity Asset

BioSpace

Tue, 01/23/24 - 06:02 pm

EraCal Therapeutics

United States of Ozempic: Where anti-obesity drugs are taking off

Axios

Fri, 01/19/24 - 09:31 am

JPM24: ‘Diabesity’ duopoly between Novo, Lilly takes center stage

Medical Marketing and Media

Thu, 01/11/24 - 11:18 am

Amgen has potential to compete with established leaders in obesity drugs

Biopharma Reporter

Thu, 01/11/24 - 11:13 am

JPM24: In booming obesity field, Novo Nordisk is 'just getting going,' CEO says

Fierce Pharma

Wed, 01/10/24 - 06:27 pm

Lars Fruergaard Jorgensen

Zepbound shortage could be around the corner

Beckers Hospital Review

Tue, 01/9/24 - 10:05 pm

JPM24: Amgen CEO hopes to take a bite of competitive obesity market with unique approach

Fierce Pharma

Tue, 01/9/24 - 10:54 am

Zealand raises $212.5M to advance obesity pipeline

Clinical Trials Arena

Tue, 01/9/24 - 09:37 am

Pfizer to remain aggressive on obesity market after setback

Reuters

Mon, 01/8/24 - 10:19 pm

Rhythm expands obesity portfolio with Phase II weight loss drug for $100m

Clinical Trials Arena

Fri, 01/5/24 - 11:21 am

Rhythm Pharmaceuticals

Lilly launches website, home delivery option for weight-loss drugs

Reuters

Thu, 01/4/24 - 10:07 am

Novo Nordisk offers 2 Flagship biotechs up to $1B total for obesity, MASH deals

Fierce Biotech

Thu, 01/4/24 - 10:06 am

Omega Therapeutics

Flagship Pioneering

Obesity drugs’ next tests, and rising threats: 3 chronic disease stories to watch

Stat

Thu, 12/21/23 - 09:52 am

Lilly tames Fauna to go on the prowl for obesity targets in $494M deal

Fierce Biotech

Thu, 12/21/23 - 09:37 am

Structure shares sink as obesity pill misses expectations in small study

BioPharma Dive

Mon, 12/18/23 - 10:17 pm

Structure Therapeutics

Obesity drug Mounjaro to surpass Ozempic with $27 billion sales in 2029

Biopharma Reporter

Mon, 12/18/23 - 11:37 am

Teva’s Ajovy yields positive data in post-hoc migraine analysis

Clinical Trials Arena

Wed, 12/6/23 - 10:20 am

Teva Pharmaceutical

post-hoc analysis

Eli Lilly's obesity drug now available in U.S. pharmacies

Reuters

Tue, 12/5/23 - 09:53 am

Roche joins obesity drug chase with $2.7B deal for startup Carmot

BioPharma Dive

Mon, 12/4/23 - 10:18 am

Carmot Therapeutics

Maker of Wegovy, Ozempic showers money on U.S. obesity doctors

Reuters

Mon, 12/4/23 - 09:35 am

Pages